Immunotherapy

雜志介紹

Immunotherapy雜志介紹

《Immunotherapy》是一本以English為主的未開放獲取國際優秀期刊，中文名稱免疫療法，本刊主要出版、報道醫學-IMMUNOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.7，最新CiteScore 指數為5。

本刊近期中國學者發表的論文主要有：

• Establishment of humanized mice and its application progress in cancer immunotherapy

  Author: Ding, Tianlong; Yu, Yang; Pan, Xiaoyuan; Chen, Hao

• Coexpression of c-Jun in multiple-chain DAP-CAR-engineered T-cells for solid tumor therapy

  Author: Xu, Tongpeng; Wang, Chen; Chen, Xiaomei; Bai, Jian; Wang, Enxiu; Sun, Ming

• Application of immune checkpoint inhibitors in immunotherapy for gastric cancer

  Author: Wu, Yi-Xiang; Zhou, Xiao-Yu; Wang, Jian-Qi; Chen, Gao-Min; Chen, Jin-Xu; Wang, Rong-Chang; Huang, Jiong-Qiang; Chen, Jing-Song

• A new perspective on the potential application of RIPK1 in the treatment of sepsis

  Author: Wang, Xuesong; Chai, Yan; Guo, Zhe; Wang, Ziyi; Liao, Haiyan; Wang, Ziwen; Wang, Zhong

英文介紹

Immunotherapy雜志英文介紹

Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.

Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.